All Posts: dementia
-
Immune-Compromised People with HIV, APOE4 Gene May Have a Compounded Risk for Alzheimer’s
WASHINGTON (February 22, 2021) — People living with the human immunodeficiency virus (HIV) who have a history of severe immunosuppression and at least one copy of the Alzheimer’s disease-related gene variant APOE4 might see a compounded adverse effect on the circuitry that impacts memory. This could eventually lead to an increased risk for dementia after […]
Category: News Release
-
Early-life Education Improves Memory in Old Age — Especially for Women
WASHINGTON (June 5, 2020) — Education appears to protect older adults, especially women, against memory loss, according to a study by investigators at Georgetown University Medical Center, published in the journal Aging, Neuropsychology, and Cognition. The results suggest that children — especially girls — who attend school for longer will have better memory abilities in […]
Category: News Release
-
Nilotinib Appears Safe and Affects Biomarkers in Alzheimer’s Disease Clinical Trial
WASHINGTON (May 29, 2020) — A Georgetown University Medical Center clinical trial investigating the cancer drug nilotinib in people with Alzheimer’s disease finds that it is safe and well-tolerated, and researchers say the drug should be tested in a larger study to further determine its safety and efficacy as a potential disease-modifying strategy. The results […]
Category: News Release
-
Seeding the Work of GUMC's Young Neuroscience Investigators
(May 30, 2013) — Talk of continued successes punctuated the conversations of more than 150 guests at Georgetown University Medical Center’s (GUMC) third annual “Music for the Mind,” a spring fundrais
Category: GUMC Stories
-
Removing Protein “Garbage” in Nerve Cells May Help Control Two Neurodegenerative Diseases
Neuroscientists at Georgetown University Medical Center say they have new evidence that challenges scientific dogma involving two fatal neurodegenerative diseases — amyotrophic lateral sclerosis (ALS), and frontotemporal dementia (FTD) — and, in the process, have uncovered a possible therapeutic target as a novel strategy to treat both disorders.
Category: News Release